Skip to content
Neoadjuvant ddMVAC (bladder) & Nivo + Chemo (NSCLC) episode artwork

Mar 10, 2022 17 min

Neoadjuvant ddMVAC (bladder) & Nivo + Chemo (NSCLC)

from OncoPharm Hosted by John Bossaer

Results from VESPER are now published, so we revisit neoadjuvant ddMVAC and its place as SOC in bladder cancer. Nivolumab nets a new approval with chemo for neoadjuvant treatment of NSCLC. A new CAR-T product is approved for multiple myeloma.

Episode details come from the podcast's RSS feed.

Embed this episode

Ready to play

Neoadjuvant ddMVAC (bladder) & Nivo + Chemo (NSCLC)

0:00 17:10

No transcript yet.

Requests help us decide what to transcribe next.

Frequently asked questions

How long is this episode of OncoPharm?

This episode is 17 minutes long.

When was this OncoPharm episode published?

This episode was published on March 10, 2022.

Can I download this OncoPharm episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.